Home > Healthcare > Biotechnology > Biotechnology R&D > Mesenchymal Stem Cells Market

Mesenchymal Stem Cells Market Size

Report ID: GMI6555
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Mesenchymal Stem Cells Market Size

Mesenchymal Stem Cells Market size accounted for USD 3 billion in 2022 and is estimated to grow at 12.8% to reach USD 10.3 billion by 2032 due to the rising prevalence of chronic diseases such as cancer, autoimmune disease, diabetes coupled with increasing implication in the field of immune therapy, drug discovery and regenerative medicine.

To get key market trends

Download Free Sample

For instance, in 2019, according to the World Health Organization (WHO), 18 million people globally were suffering from rheumatoid arthritis. Thus, rising prevalence of autoimmune disease is significantly propelling the demand for mesenchymal stem cells to develop effective therapies. Furthermore, increasing R&D activities by biopharmaceutical companies and growing application of mesenchymal stem cells in toxicology and safety testing.

Mesenchymal Stem Cells Market Report Attributes
Report Attribute	Details
Base Year:	2022
Mesenchymal Stem Cells Market Size in 2022:	USD 3 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	12.8%
2032 Value Projection:	USD 10.3 Billion
Historical Data for:	2018 to 2022
No. of Pages:	180
Tables, Charts & Figures:	391
Segments covered:	Products & Services, Type, Source, Indication, Application, and Region
Growth Drivers:	Growing awareness regarding regenerative medicine Evolving diverse applications of mesenchymal stem cells Rising prevalence of chronic diseases
Pitfalls & Challenges:	High cost of associated with stem cell treatment Lack of standardized & regulated delivery of stem cell therapy

Learn more about the key segments shaping this market

Download Free Sample

Mesenchymal stem cells (MSCs) are a type of multipotent stem cells that can differentiate into various cell types like bone, cartilage, and fat within the body's mesodermal lineage. These cells are found in various tissues of the body, such as bone marrow, adipose tissue, umbilical cord among others that possess self-renewal capabilities, enabling them to multiply and generate more MSCs. These cells offer distinctive feature and their ability to modulate the immune system, make them appealing for therapeutic applications in areas such as tissue repair, regenerative medicine, and immune modulation.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for mesenchymal stem cells accounted for USD 3 billion in 2022 and is estimated to grow at 12.8% CAGR from 2023 to 2032, backed by the rising prevalence of chronic diseases such as cancer, autoimmune disease, diabetes, and others.

The products segment accounted for 76.8% of the market share in 2022 and is projected to witness robust growth through 2032. Products like kits and reagents designed for mesenchymal stem cells research streamline experimental processes, ensuring accuracy and reproducibility.

North America market accounted for 42.4% revenu share in 2022 and is anticipated to grow at considerable growth rate owing to robust research infrastructure coupled with a strong emphasis on medical innovation, leading to a thriving MSC-related advancements.

Thermo Fisher Scientific, Inc., Cell Applications, Inc., Cyagen Biosciences, Lonza, PromoCell GmbH among others.